CN110930167A - Block chain-based medicine information recording method, equipment and medium - Google Patents
Block chain-based medicine information recording method, equipment and medium Download PDFInfo
- Publication number
- CN110930167A CN110930167A CN201911149886.5A CN201911149886A CN110930167A CN 110930167 A CN110930167 A CN 110930167A CN 201911149886 A CN201911149886 A CN 201911149886A CN 110930167 A CN110930167 A CN 110930167A
- Authority
- CN
- China
- Prior art keywords
- information
- medicine
- drug
- block chain
- medicine information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 234
- 238000000034 method Methods 0.000 title claims abstract description 56
- 229940079593 drug Drugs 0.000 claims abstract description 102
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 238000003860 storage Methods 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 3
- 238000012795 verification Methods 0.000 abstract description 7
- 230000007246 mechanism Effects 0.000 abstract description 6
- 238000012423 maintenance Methods 0.000 abstract description 4
- 238000010586 diagram Methods 0.000 description 8
- 238000004590 computer program Methods 0.000 description 7
- 238000007689 inspection Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012797 qualification Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000003962 counterfeit drug Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012550 audit Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/018—Certifying business or products
- G06Q30/0185—Product, service or business identity fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/60—Protecting data
- G06F21/602—Providing cryptographic facilities or services
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/60—Protecting data
- G06F21/64—Protecting data integrity, e.g. using checksums, certificates or signatures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K17/00—Methods or arrangements for effecting co-operative working between equipments covered by two or more of main groups G06K1/00 - G06K15/00, e.g. automatic card files incorporating conveying and reading operations
- G06K17/0022—Methods or arrangements for effecting co-operative working between equipments covered by two or more of main groups G06K1/00 - G06K15/00, e.g. automatic card files incorporating conveying and reading operations arrangements or provisious for transferring data to distant stations, e.g. from a sensing device
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F2221/00—Indexing scheme relating to security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F2221/21—Indexing scheme relating to G06F21/00 and subgroups addressing additional information or applications relating to security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F2221/2141—Access rights, e.g. capability lists, access control lists, access tables, access matrices
Landscapes
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Computer Security & Cryptography (AREA)
- Business, Economics & Management (AREA)
- General Engineering & Computer Science (AREA)
- Computer Hardware Design (AREA)
- Software Systems (AREA)
- General Health & Medical Sciences (AREA)
- Bioethics (AREA)
- Health & Medical Sciences (AREA)
- Development Economics (AREA)
- Accounting & Taxation (AREA)
- Entrepreneurship & Innovation (AREA)
- Economics (AREA)
- Finance (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The application discloses a method, equipment and medium for recording medicine information based on a block chain. The medicine information recording method based on the block chain comprises the steps of checking identity identification information and confirming whether the medicine information recording method has information input authority, if yes, the method comprises the following steps: receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information; associating and uploading the drug information with the drug identification code to a drug identification block chain; and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction. The medicine information recording method is based on the block chain, a multi-party maintenance consensus mechanism is introduced, the medicine information input authority is not controlled by a single main body in a unilateral manner, and the consensus is formed by multi-party verification of all nodes on the block chain, so that the medicine information can be written in, the possibility that the medicine data are illegally tampered is effectively prevented, and a consumer or other demand parties obtain authoritative, reliable and traceable medicine information data.
Description
Technical Field
The present application relates to the field of medical product information technologies, and in particular, to a method, an apparatus, and a medium for recording medicine information based on a blockchain.
Background
In recent years, the problem of counterfeit drugs is always puzzling consumers, and many people suffer from the problems and have pain in disguising the counterfeit drugs. The consumer has higher expectation on the safety of the medicine, and the importance of true and accurate medicine information is more prominent. When purchasing goods, especially medicines, consumers often worry about the truth and falseness of the medicines, the quality and the normality of circulation channels. When the medicine is sold, the medicine production enterprises also need to master the goods spreading condition of the medicine, and effectively manage the medicine sale, on one hand, the medicine with problems can be recalled quickly, and on the other hand, the illegal persons are prevented from imitating the medicine produced and sold by the illegal persons.
At present, some medicine information recording methods and technologies exist, but the existing methods and technologies have certain defects. Firstly, in the existing medicine information recording method, the input authority of information is unilaterally controlled by a single main body, and the input and stored data can be tampered or forged, so that the authenticity and authority of the data cannot be guaranteed. Secondly, the counterfeit and tampering behaviors of the medicine information lack the supervision force, the data tampering or counterfeiting condition cannot be timely and effectively found, and the supervision missing position is easily caused. In addition, insufficient storage of evidence causes difficulty in tracing the discipline.
At present, no method for effectively preventing a single main body from modifying medicine information data exists, so that a consumer or other demanders can easily obtain real and reliable medicine information, and each link of medicine production, circulation and detection is effectively supervised and information can be traced in the whole process.
Therefore, there is an urgent need to develop a novel drug information recording method, which can ensure that the whole life cycle, the whole process and the whole element information of drug production, circulation and detection are truly and effectively recorded, prevent information from being tampered, trace drug information, tamper or counterfeit and trace back, and construct a brand new trust mechanism of the drug quality for consumers.
Disclosure of Invention
The embodiment of the specification provides a method, equipment and a medium for recording medicine information based on a block chain, which are used for solving the following technical problems in the prior art: the information input authority is unilaterally controlled by a single main body, supervision missing is easily caused, the information input main body can modify, even tamper and counterfeit the input information, and the problem that the input information cannot be traced is solved.
The embodiment of the specification adopts the following technical scheme:
a block chain-based medicine information recording method comprises the following steps:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
Optionally, the method for recording medicine information based on a blockchain further includes:
and constructing identity identification information, wherein the step of constructing the identity identification information at least comprises the steps of setting a private key and sending the private key to an input terminal with information input authority.
Optionally, the method for recording medicine information based on a blockchain further includes:
and constructing an information input intelligent contract, wherein the information input intelligent contract at least comprises the step of determining whether the input terminal has the information input authority according to the private key.
Optionally, the verifying the identification information at least includes obtaining an input password and verifying whether the password is consistent with a set private key.
Optionally, the acquiring of the drug information at least includes acquiring drug information provided by one of a drug raw material provider, a drug manufacturer, a drug purchaser, and a hospital.
Optionally, the drug information includes at least one of: drug production information, drug circulation information, drug detection information.
Optionally, the method for recording medicine information based on a blockchain further includes:
constructing a drug information disclosure platform, wherein the drug information disclosure platform at least comprises one of the following items: computer, mobile intelligent terminal, wisdom large screen.
Optionally, the drug identification code comprises at least one of: two-dimensional code, bar code, RFID label.
A block chain-based medicine information recording apparatus comprising:
at least one processor; and the number of the first and second groups,
a memory communicatively coupled to the at least one processor; wherein the content of the first and second substances,
the memory stores instructions executable by the at least one processor to enable the at least one processor to:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
A non-transitory computer storage medium for blockchain-based drug information recording, the computer storage medium having stored thereon computer-executable instructions configured to:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
The embodiment of the specification adopts at least one technical scheme which can achieve the following beneficial effects: the medicine information recording method is based on the block chain, a multi-party maintenance consensus mechanism is introduced, the medicine information input authority is not controlled by a single main body in a single direction, and the medicine information can be written only by multi-party verification of each node on the block chain to form consensus. Before inputting medicine information, firstly, the identity identification information of an input terminal is checked to confirm whether the input terminal has the information input authority, and only the input terminal which is authenticated by multiple parties has the authority to input the medicine information on a medicine identification block chain. Therefore, the input authority is effectively prevented from being controlled by a single main body in a unilateral manner, the possibility that data is falsified or counterfeited is effectively prevented, and a consumer can obtain authoritative, reliable and traceable medicine information.
Drawings
The accompanying drawings, which are included to provide a further understanding of the application and are incorporated in and constitute a part of this application, illustrate embodiment(s) of the application and together with the description serve to explain the application and not to limit the application. In the drawings:
fig. 1 is a schematic flowchart of a method for recording medicine information based on a block chain according to an embodiment of the present disclosure.
Detailed Description
In order to make the objects, technical solutions and advantages of the present disclosure more apparent, the technical solutions of the present disclosure will be clearly and completely described below with reference to the specific embodiments of the present disclosure and the accompanying drawings. It should be apparent that the described embodiments are only some of the embodiments of the present application, and not all of the embodiments. All other embodiments obtained by a person skilled in the art without making any inventive step based on the embodiments in the description belong to the protection scope of the present application.
The technical solutions provided by the embodiments of the present application are described in detail below with reference to the accompanying drawings.
The scheme of the application provides a block chain-based medicine information recording method and a corresponding scheme. Fig. 1 is a schematic flowchart of a method for recording medicine information based on a block chain according to an embodiment of the present disclosure. The medicine information recording method based on the block chain comprises the steps of checking identity identification information and confirming whether the medicine information recording method has information input authority, if yes, the method comprises the following steps: receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information; associating and uploading the drug information with the drug identification code to a drug identification block chain; and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
At present, the input authority of the medicine information is unidirectionally mastered by a single main body. For example, a drug material supplier provides drug material information and inputs the drug material information to a database, a drug manufacturer provides drug production information, and a drug purchaser, a hospital, or the like provides distribution information of the drug. Since various information of the medicine is provided by a single body, the medicine information is suspected to be beautifully recognized and may be falsified or forged. In order to obtain more fair and objective medicine information, the block chain-based medicine information recording method provided by the embodiment of the application introduces a multi-party maintenance consensus mechanism, and uniquely gives the medicine information input authority to an input terminal obtaining multi-party verification consensus on the block chain, so that the possibility of beautifying, tampering and even counterfeiting the medicine information is effectively prevented.
In some embodiments of the present application, the input terminal may be a drug raw material provider, a drug manufacturer, a drug purchaser, or a hospital, a third party entity such as a government, a regulatory agency, a testing facility, or a consumer or other party in need thereof.
The pharmaceutical material supplier provides information such as at least a detection report of the raw material, a certificate of the merchant, and a purchase price of the raw material from the purchased raw material as a starting point. The pharmaceutical manufacturer provides at least qualification information of the pharmaceutical factory, processing information of the pharmaceutical at each step of the manufacturing process, and also provides charitable information and accident information of the pharmaceutical factory. The buyer of the hospital or pharmacy provides at least the information of the responsible person for purchasing the hospital or pharmacy and the marketing qualification information of the hospital or pharmacy, and besides, the accident information of the hospital also needs to be provided.
The medicine information mastered by third-party subjects such as governments, supervision departments, detection institutions and the like is objective and fair, and has better credibility. For a part of production data, such as enterprise qualification, enterprise registration information, product production permission, etc., due to the mandatory regulations of the country or industry, pharmaceutical manufacturers will register at these third-party entities, and the registered part of drug information can also be provided by these third-party entities, so that it is more reliable. In addition, the third party principal may provide inspection data including government inspection data, sampling inspection data of a regulatory department, inspection condition reports of an inspection institution, and the like.
The consumer or other demanding parties are direct users of the medicine and are also actual visitors of the quality of the medicine, so that the quality of the medicine is relatively pronounced. At present, a consumer often has no authority or method to feed back medicine quality information, and a general and relatively fair platform to disclose feedback data of the consumer on medicine quality is lacked.
The data provided by the drug raw material provider, the drug manufacturer, the drug buyer, the hospital, the supervision department, the detection institution or the consumer and other demanders are gathered together for cross-comparison and audit. The relatively real and objective medicine information provided by the third-party main body or the consumer and the like can be used for evidentiary verification of the medicine information provided by the manufacturer and the like, so that the authenticity and the effectiveness of the medicine information uploaded to the medicine identification block chain are ensured.
In some embodiments of the present application, the method for block chain-based drug information recording further includes constructing identification information, where constructing identification information at least includes setting a private key and sending the private key to an input terminal having an information input right. Before the medicine information data writing chain, all nodes on the medicine identification block chain select a unique medicine information input terminal through a consensus mechanism, set a unique private key and send the private key to the unique terminal with the information input right. On the other hand, the private key is created, and the drug identification block chain identity based on the private key is created, so that the privacy and the rights and interests of the input terminal can be effectively guaranteed.
In some embodiments of the present application, the method for block chain-based drug information recording further includes constructing an information input intelligent contract, where the information input intelligent contract includes at least determining whether the input terminal has information input authority according to a private key. The intelligent contract is a built-in contract formed by an algorithm code based on a rule agreed in advance, and the automation and the intelligence of the performance can be realized by arranging the intelligent contract on a block chain. On the other hand, the intelligent contract can only be changed in an upgrading mode, all nodes need to be deployed synchronously, once the intelligent contract is deployed, the intelligent contract can only be executed through a program, and human factor interference is avoided, so that the stability and the credibility of the writing chain operation on the medicine information identification block chain are enhanced.
In some embodiments of the present application, verifying the identification information of the input terminal on the drug identification blockchain includes at least obtaining an input password and verifying whether the password is consistent with a set private key. Before the input terminal writes a chain, the input terminal sends a password to the medicine identification block chain, and the identity identification information of the input terminal is checked by verifying whether the password sent by the input terminal is consistent with a private key set by the block chain, so as to determine whether the input terminal has information input authority.
The medicine information written by the input terminal with information input authority includes at least one of the following items: drug production information, drug circulation information, drug detection information.
The drug production information may be data directly used in the production process, or other data capable of indirectly guiding production or subsequent production improvement, such as drug raw material information, drug water use information, manufacturer qualification, standard statement, and the like. The medicine circulation information includes, for example, medicine health information, production equipment information, production environment information, production process, product certification, production flow data, and the like. The medicine detection information includes, for example, a factory detection certificate of the medicine, a certificate of a third party detection authority, a certificate of a regulatory authority, and the like. For example, the system can also comprise government detection data, sampling inspection data of a supervision department, detection condition reports of a detection organization and the like.
And the input terminal with the information input authority associates the medicine information with the unique medicine identification code and uploads the medicine information to the medicine identification block chain. The drug identification code may include, for example, at least one of: two-dimensional code, bar code, RFID label. The drug information demander can acquire the drug information uploaded to the drug identification block chain in a mode of scanning the drug identification code.
In some embodiments of the present application, the blockchain-based drug information recording method further comprises constructing a drug information presentation platform. The medicine information public display platform can be displayed on access terminals such as a computer, a mobile intelligent terminal and an intelligent large screen by adopting a built block chain browser. The drug information demander can send a drug information reading request in a code scanning mode and the like, and the drug information publicizing platform publicizes the drug information after receiving the request. The fact that the medicine information is disclosed can further improve the supervision of the authenticity and the accuracy of the medicine information by governments, supervision departments, consumers or other demanders.
A medicine information recording method based on a block chain introduces a multi-party maintenance consensus mechanism, the medicine information input authority is not unilaterally controlled by a single main body, and the medicine information can be written in only by forming consensus through multi-party verification of each node on the block chain. Before medicine information is input, the medicine information to be chain-wound provided by multiple parties is subjected to summary verification, comparison and verification, after the authenticity and accuracy of the medicine to be chain-wound are confirmed, the medicine information is written into a medicine identification block chain by an input terminal obtaining information input authority, and then the medicine information is disclosed to a medicine information demand party. Therefore, the input authority is effectively prevented from being controlled by a single main body in a unilateral manner, the possibility that data is falsified or counterfeited is effectively prevented, and a consumer can obtain authoritative, reliable and traceable medicine information.
Based on the same idea, some embodiments of the present application further provide a device and a non-volatile computer storage medium corresponding to the above-described platform.
Some embodiments of the present application provide a blockchain-based drug information recording apparatus corresponding to fig. 1, including:
at least one processor; and the number of the first and second groups,
a memory communicatively coupled to the at least one processor; wherein the content of the first and second substances,
the memory stores instructions executable by the at least one processor to enable the at least one processor to:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
Some embodiments of the present application provide a non-volatile computer storage medium corresponding to a blockchain-based drug information record of fig. 1, having stored thereon computer-executable instructions configured to:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
The embodiments in the present application are described in a progressive manner, and the same and similar parts among the embodiments can be referred to each other, and each embodiment focuses on the differences from the other embodiments. In particular, for the device and media embodiments, the description is relatively simple as it is substantially similar to the method embodiments, and reference may be made to some descriptions of the method embodiments for relevant points.
The device and the medium provided by the embodiment of the application correspond to the method one to one, so the device and the medium also have the similar beneficial technical effects as the corresponding method, and the beneficial technical effects of the method are explained in detail above, so the beneficial technical effects of the device and the medium are not repeated herein.
As will be appreciated by one skilled in the art, embodiments of the present invention may be provided as a method, system, or computer program product. Accordingly, the present invention may take the form of an entirely hardware embodiment, an entirely software embodiment or an embodiment combining software and hardware aspects. Furthermore, the present invention may take the form of a computer program product embodied on one or more computer-usable storage media (including, but not limited to, disk storage, CD-ROM, optical storage, and the like) having computer-usable program code embodied therein.
The present invention is described with reference to flowchart illustrations and/or block diagrams of methods, apparatus (systems), and computer program products according to embodiments of the invention. It will be understood that each flow and/or block of the flow diagrams and/or block diagrams, and combinations of flows and/or blocks in the flow diagrams and/or block diagrams, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, embedded processor, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.
These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the flowchart flow or flows and/or block diagram block or blocks.
These computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.
In a typical configuration, a computing device includes one or more processors (CPUs), input/output interfaces, network interfaces, and memory.
The memory may include forms of volatile memory in a computer readable medium, Random Access Memory (RAM) and/or non-volatile memory, such as Read Only Memory (ROM) or flash memory (flash RAM). Memory is an example of a computer-readable medium.
Computer-readable media, including both non-transitory and non-transitory, removable and non-removable media, may implement information storage by any method or technology. The information may be computer readable instructions, data structures, modules of a program, or other data. Examples of computer storage media include, but are not limited to, phase change memory (PRAM), Static Random Access Memory (SRAM), Dynamic Random Access Memory (DRAM), other types of Random Access Memory (RAM), Read Only Memory (ROM), Electrically Erasable Programmable Read Only Memory (EEPROM), flash memory or other memory technology, compact disc read only memory (CD-ROM), Digital Versatile Discs (DVD) or other optical storage, magnetic cassettes, magnetic tape magnetic disk storage or other magnetic storage devices, or any other non-transmission medium that can be used to store information that can be accessed by a computing device. As defined herein, a computer readable medium does not include a transitory computer readable medium such as a modulated data signal and a carrier wave.
It should also be noted that the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising an … …" does not exclude the presence of other like elements in a process, method, article, or apparatus that comprises the element.
The above description is only an example of the present application and is not intended to limit the present application. Various modifications and changes may occur to those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the scope of the claims of the present application.
Claims (10)
1. A method for recording medicine information based on a block chain is characterized by comprising the following steps:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
2. The method for recording block chain-based medicine information according to claim 1, further comprising:
and constructing identity identification information, wherein the step of constructing the identity identification information at least comprises the steps of setting a private key and sending the private key to an input terminal with information input authority.
3. The method for recording medicine information based on a blockchain according to claim 2, further comprising:
and constructing an information input intelligent contract, wherein the information input intelligent contract at least comprises the step of determining whether the input terminal has the information input authority according to the private key.
4. The block chain-based medicine information recording method according to claim 2, wherein:
and the step of verifying the identity identification information at least comprises the steps of acquiring an input password and verifying whether the password is consistent with a set private key.
5. The block chain-based medicine information recording method according to any one of claims 1 to 4, wherein:
the acquiring of the medicine information at least comprises acquiring the medicine information provided by one of a medicine raw material provider, a medicine manufacturer, a medicine purchaser and a hospital.
6. The block chain-based medicine information recording method according to claim 5, wherein:
the drug information includes at least one of: drug production information, drug circulation information, drug detection information.
7. The method for recording block chain-based medicine information according to claim 1, further comprising:
constructing a drug information disclosure platform, wherein the drug information disclosure platform at least comprises one of the following items: computer, mobile intelligent terminal, wisdom large screen.
8. The block chain-based medicine information recording method according to claim 1, wherein:
the drug identification code includes at least one of: two-dimensional code, bar code, RFID label.
9. A block chain-based medicine information recording apparatus, comprising:
at least one processor; and the number of the first and second groups,
a memory communicatively coupled to the at least one processor; wherein the content of the first and second substances,
the memory stores instructions executable by the at least one processor to enable the at least one processor to:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
10. A non-transitory computer storage medium for blockchain-based drug information recording, the computer storage medium having stored thereon computer-executable instructions configured to:
checking the identity identification information, and confirming whether the information input authority exists, if so, then:
receiving an input instruction and inputting an intelligent contract according to information to acquire medicine information;
associating the drug information with a drug identification code and uploading the drug information to a drug identification block chain;
and receiving an access instruction, wherein the access instruction comprises an identification code of the medicine, and the medicine information is disclosed according to the access instruction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911149886.5A CN110930167A (en) | 2019-11-21 | 2019-11-21 | Block chain-based medicine information recording method, equipment and medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911149886.5A CN110930167A (en) | 2019-11-21 | 2019-11-21 | Block chain-based medicine information recording method, equipment and medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110930167A true CN110930167A (en) | 2020-03-27 |
Family
ID=69850614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911149886.5A Pending CN110930167A (en) | 2019-11-21 | 2019-11-21 | Block chain-based medicine information recording method, equipment and medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110930167A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112184268A (en) * | 2020-10-27 | 2021-01-05 | 广州市家庭医生在线信息有限公司 | Medicine traceability management method and system based on block chain technology |
| CN112699180A (en) * | 2020-12-24 | 2021-04-23 | 广东工业大学 | Medicine recall system and method based on block chain |
| CN113553625A (en) * | 2020-04-23 | 2021-10-26 | 陕西尚品信息科技有限公司 | Method and device for recording medicine data, electronic equipment and storage medium |
| CN117493338A (en) * | 2023-11-02 | 2024-02-02 | 北京易华录信息技术股份有限公司 | Data blood relationship identification and storage system based on blockchain |
| CN117649247A (en) * | 2023-11-24 | 2024-03-05 | 好心情健康产业集团有限公司 | Drug tracing method and device |
-
2019
- 2019-11-21 CN CN201911149886.5A patent/CN110930167A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113553625A (en) * | 2020-04-23 | 2021-10-26 | 陕西尚品信息科技有限公司 | Method and device for recording medicine data, electronic equipment and storage medium |
| CN112184268A (en) * | 2020-10-27 | 2021-01-05 | 广州市家庭医生在线信息有限公司 | Medicine traceability management method and system based on block chain technology |
| CN112699180A (en) * | 2020-12-24 | 2021-04-23 | 广东工业大学 | Medicine recall system and method based on block chain |
| CN117493338A (en) * | 2023-11-02 | 2024-02-02 | 北京易华录信息技术股份有限公司 | Data blood relationship identification and storage system based on blockchain |
| CN117649247A (en) * | 2023-11-24 | 2024-03-05 | 好心情健康产业集团有限公司 | Drug tracing method and device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sylim et al. | Blockchain technology for detecting falsified and substandard drugs in distribution: pharmaceutical supply chain intervention | |
| CN110930167A (en) | Block chain-based medicine information recording method, equipment and medium | |
| CN111008844A (en) | Block chain-based drug tracing method, device and medium | |
| US11720888B2 (en) | Decentralized title transfer and validation of assets | |
| RU2639015C1 (en) | Authenticity and quality control procedure of production in the process of manufacture and implementation | |
| US20240177100A1 (en) | Methods and apparatus for performing agricultural transactions | |
| CN111429162A (en) | Energized block chain agricultural product quality credible traceability system based on nondestructive detection technology | |
| US20190188732A1 (en) | System and method for ensuring credibility of items in a supply chain management | |
| Kwok et al. | A counterfeit network analyzer based on RFID and EPC | |
| CN104252677A (en) | Two-dimension code anti-counterfeiting technology and two-dimension code anti-counterfeiting system-based platform system | |
| CN111445273A (en) | Anti-counterfeiting traceability information processing method and system based on block chain | |
| CN109461008A (en) | Drug Administration method and system based on block chain | |
| CN112184268A (en) | Medicine traceability management method and system based on block chain technology | |
| CN111415170A (en) | Block chain-based food tracing method and equipment and related storage medium | |
| CN111311282A (en) | Commodity anti-counterfeiting verification method and system based on block chain | |
| CN107977845A (en) | Food traceability system and method based on label information | |
| CN112288441A (en) | Method, equipment and medium for tracing imported frozen meat based on block chain | |
| CN112036914A (en) | Block chain-based edible agricultural product quality certificate management method, equipment and medium | |
| US10193883B2 (en) | Systems and methods for product authentication | |
| CN114723462A (en) | Chinese herbal medicine storage quality management system based on block chain technology | |
| CN114386988A (en) | Anti-counterfeiting tracing method and device and electronic equipment | |
| CN110069937A (en) | Data source tracing method, system and device based on block chain | |
| CN111274608A (en) | Block chain-based enterprise authority management method, equipment and medium | |
| Durá et al. | Blockchain for data originality in pharma manufacturing | |
| CN111091392A (en) | Furniture tracing method, equipment and medium based on block chain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20200814 Address after: Room 1-2301, Building 7, North District, Shandong Design and Creative Industry Park, No. 868 Tangye West Road, Licheng District, Jinan City, Shandong Province, 250102 Applicant after: SHANDONG INSPUR QUALINK TECHNOLOGY Co.,Ltd. Address before: Room 3110, S01 building, Langchao building, No. 1036, Langchao Road, high tech Zone, Jinan City, Shandong Province 250101 Applicant before: Shandong Aicheng Network Information Technology Co.,Ltd. |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |